Fujii S - Search Results

1

A set of genes associated with the interferon-γ response of lung cancer patients undergoing α-galactosylceramide-pulsed dendritic cell therapy.

Okita K, Motohashi S, Shinnakasu R, Nagato K, Yamasaki K, Sato Y, Kitamura H, Hijikata A, Yamashita M, Shimizu K, Fujii S, Ohara O, Taniguchi M, Sakaida I, Nakayama T. Okita K, et al. Among authors: fujii s. Cancer Sci. 2010 Nov;101(11):2333-40. doi: 10.1111/j.1349-7006.2010.01696.x. Cancer Sci. 2010. PMID: 20804502 Free PMC article.

2

Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.

Fujii S, Shimizu K, Kronenberg M, Steinman RM. Fujii S, et al. Nat Immunol. 2002 Sep;3(9):867-74. doi: 10.1038/ni827. Epub 2002 Aug 5. Nat Immunol. 2002. PMID: 12154358

3

Detection and activation of human Valpha24+ natural killer T cells using alpha-galactosyl ceramide-pulsed dendritic cells.

Fujii S, Shimizu K, Steinman RM, Dhodapkar MV. Fujii S, et al. J Immunol Methods. 2003 Jan 15;272(1-2):147-59. doi: 10.1016/s0022-1759(02)00497-0. J Immunol Methods. 2003. PMID: 12505720

4

Malignant counterpart of myeloid dendritic cell (DC) belonging to acute myelogenous leukemia (AML) exhibits a dichotomous immunoregulatory potential.

Fujii S, Shimizu K, Koji F, Kawano F. Fujii S, et al. J Leukoc Biol. 2003 Jan;73(1):82-90. doi: 10.1189/jlb.0602267. J Leukoc Biol. 2003. PMID: 12525565

5

A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma.

Dhodapkar MV, Geller MD, Chang DH, Shimizu K, Fujii S, Dhodapkar KM, Krasovsky J. Dhodapkar MV, et al. Among authors: fujii s. J Exp Med. 2003 Jun 16;197(12):1667-76. doi: 10.1084/jem.20021650. Epub 2003 Jun 9. J Exp Med. 2003. PMID: 12796469 Free PMC article.

6

Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein.

Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM. Fujii S, et al. J Exp Med. 2003 Jul 21;198(2):267-79. doi: 10.1084/jem.20030324. J Exp Med. 2003. PMID: 12874260 Free PMC article.

7

Severe and selective deficiency of interferon-gamma-producing invariant natural killer T cells in patients with myelodysplastic syndromes.

Fujii S, Shimizu K, Klimek V, Geller MD, Nimer SD, Dhodapkar MV. Fujii S, et al. Br J Haematol. 2003 Aug;122(4):617-22. doi: 10.1046/j.1365-2141.2003.04465.x. Br J Haematol. 2003. PMID: 12899717 Free article.

8

Valpha14 NKT cell-mediated anti-tumor responses and their clinical application.

Seino K, Fujii S, Harada M, Motohashi S, Nakayama T, Fujisawa T, Taniguchi M. Seino K, et al. Among authors: fujii s. Springer Semin Immunopathol. 2005 Jun;27(1):65-74. doi: 10.1007/s00281-004-0194-y. Epub 2005 Jan 14. Springer Semin Immunopathol. 2005. PMID: 15650847 Review.

9

Regulatory balance between the immune response of tumor antigen-specific T-cell receptor gene-transduced CD8 T cells and the suppressive effects of tolerogenic dendritic cells.

Fujii S, Nishimura MI, Lotze MT. Fujii S, et al. Cancer Sci. 2005 Dec;96(12):897-902. doi: 10.1111/j.1349-7006.2005.00124.x. Cancer Sci. 2005. PMID: 16367910 Free PMC article.

10

Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice.

Fujii S, Shimizu K, Hemmi H, Fukui M, Bonito AJ, Chen G, Franck RW, Tsuji M, Steinman RM. Fujii S, et al. Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11252-7. doi: 10.1073/pnas.0604812103. Epub 2006 Jul 14. Proc Natl Acad Sci U S A. 2006. PMID: 16844772 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,815 results

Search Page

Filters